ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding ProQR Therapeutics N.V. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 67 | 2 | 74 | +9 |
| Shares | 39.8M | 51.9K | 45.4M | +5.67M (+14.2%) |
| Value | $333.4M | $434.0K | $364.8M | +$31.8M (+9.6%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held ProQR Therapeutics N.V. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Privium Fund Management B.V. | 4,765,659 | $38.9M | 7.76% |
| Alps Advisors Inc | 82,338 | $660.0K | 0.01% |
| Corton Capital Inc. | 34,997 | $280.0K | 0.12% |
| D. E. Shaw & Co., Inc. | 33,682 | $270.0K | 0.00% |
| Coastal Bridge Advisors, LLC | 21,200 | $170.0K | 0.04% |
| Brown Advisory Inc | 18,872 | $151.0K | 0.00% |
| Simplex Trading, LLC | 16,291 | $130.0K | 0.00% |
| D.A. Davidson & Co. | 15,772 | $126.0K | 0.00% |
| Delphia (USA) Inc. | 13,480 | $108.0K | 0.11% |
| ProShare Advisors LLC | 10,020 | $80.0K | 0.00% |
| Dorsey Wright & Associates | 6,860 | $55.0K | 0.01% |
| Northern Trust Corp | 6,330 | $51.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 2,326 | $18.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,934 | $16.0K | 0.00% |
| Spire Wealth Management | 2,001 | $16.0K | 0.00% |
| Total Clarity Wealth Management, Inc. | 1,500 | $12.0K | 0.01% |
| Beaird Harris Wealth Management, LLC | 999 | $8.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 167 | $1.00K | 0.00% |
Sold out (9)
Institutions that held ProQR Therapeutics N.V. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 137,003 | $1.15M |
| Two Sigma Investments, LP | 133,941 | $1.12M |
| Altium Capital Management LP | 125,000 | $1.05M |
| Alpha Paradigm Partners, LLC | 44,323 | $371.0K |
| Boothbay Fund Management, LLC | 18,191 | $152.0K |
| Squarepoint Ops LLC | 18,049 | $151.0K |
| Two Sigma Advisers, LP | 12,700 | $106.0K |
| Ameriprise Financial Inc | 11,200 | $94.0K |
| Captrust Financial Advisors | 7,500 | $63.0K |
Not filed for Q4 2021 yet (2)
Institutions that held ProQR Therapeutics N.V. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Copernicus Capital Management, LLC | 40,000 | $335.0K |
| HighPoint Advisor Group LLC | 11,850 | $99.0K |